Measles, Mumps and Rubella (MMR) vaccine (2027)

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06a254-2026-06-19T10:52:07+01:00",
    "date": "2026-06-19T10:52:07+01:00",
    "ocid": "ocds-h6vhtk-06a254",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "048305-2026",
                "documentType": "plannedProcurementNotice",
                "noticeType": "UK1",
                "description": "Pipeline notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/048305-2026",
                "datePublished": "2026-05-22T19:31:25+01:00",
                "format": "text/html"
            },
            {
                "id": "057104-2026",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/057104-2026",
                "datePublished": "2026-06-17T12:54:49+01:00",
                "format": "text/html"
            }
        ],
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "The UK Health Security Agency sent a short pre-market engagement questionnaire to known UK licensed suppliers of measles, mumps and rubella vaccine. Insights collected primarily focused on product, volumes and supply chain to better understand the current market landscape.",
                "dateMet": "2026-06-09T00:00:00+01:00",
                "status": "met"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-PPON-PBMQ-7576-DVGW",
            "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBMQ-7576-DVGW"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "email": "vmc.vaccines@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBMQ-7576-DVGW",
        "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
    },
    "tender": {
        "id": "CM/PHV/27/C403968",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Measles, Mumps and Rubella (MMR) vaccine (2027)",
        "description": "This tender notice is for the award of a public contract (s) through an open procedure in accordance with section 20(1) and (2)(a) of the PA 2023. For the provision of a vaccine to protect against measles, mumps and rubella, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the optional flex to be up to 1.12m doses. Deliveries will be required over a 29 month period. The awarding of lots is not appropriate for this procurement. To access this competition: Access via https://health-family.force.com/s/Welcome and view live opportunities, to view opportunity C403968.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33651600",
                        "description": "Vaccines"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33651640",
                        "description": "Measles-mumps-rubella vaccines"
                    }
                ],
                "relatedLot": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "mainProcurementCategory": "goods",
        "lots": [
            {
                "id": "1",
                "contractPeriod": {
                    "startDate": "2027-05-01T00:00:00+01:00",
                    "endDate": "2029-09-30T23:59:59+01:00"
                },
                "status": "active",
                "value": {
                    "amountGross": 0,
                    "amount": 0,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "weightingDescription": "Full details of the award criteria can be found in the tender documentation",
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Quality criterion",
                            "description": "Comparison with specification"
                        },
                        {
                            "type": "cost",
                            "name": "Cost criterion",
                            "description": "Benchmark price"
                        },
                        {
                            "type": "cost",
                            "name": "Cost criterion",
                            "description": "Vaccine price"
                        },
                        {
                            "type": "cost",
                            "name": "Cost criterion",
                            "description": "Additional costs"
                        },
                        {
                            "type": "cost",
                            "name": "Cost criterion",
                            "description": "Additional savings"
                        },
                        {
                            "type": "quality",
                            "name": "Quality criterion",
                            "description": "Risk to programme delivery"
                        },
                        {
                            "type": "quality",
                            "name": "Quality criterion",
                            "description": "Social value"
                        },
                        {
                            "type": "cost",
                            "name": "Cost criterion",
                            "description": "Storage costs"
                        }
                    ]
                },
                "selectionCriteria": {
                    "criteria": [
                        {
                            "type": "economic",
                            "description": "Covered in PSQ"
                        },
                        {
                            "type": "technical",
                            "description": "Covered in PSQ"
                        }
                    ]
                }
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-06-19T23:59:59+01:00"
        },
        "status": "active",
        "value": {
            "amountGross": 0,
            "amount": 0,
            "currency": "GBP"
        },
        "aboveThreshold": true,
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ],
        "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
        "submissionTerms": {
            "electronicSubmissionPolicy": "allowed",
            "languages": [
                "en"
            ]
        },
        "tenderPeriod": {
            "endDate": "2026-07-24T13:00:00+01:00"
        },
        "enquiryPeriod": {
            "endDate": "2026-07-10T13:00:00+01:00"
        },
        "awardPeriod": {
            "endDate": "2026-11-09T23:59:59Z"
        },
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest"
            },
            {
                "id": "057925-2026",
                "documentType": "tenderNotice",
                "noticeType": "UK4",
                "description": "Tender notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/057925-2026",
                "datePublished": "2026-06-19T10:52:07+01:00",
                "format": "text/html"
            }
        ],
        "hasRecurrence": true,
        "recurrence": {
            "dates": [
                {
                    "startDate": "2028-04-03T23:59:59+01:00"
                }
            ]
        },
        "contractTerms": {
            "financialTerms": "Standard 30 day payment terms"
        },
        "riskDetails": "The below known unknown risks has been identified, which may require modification of the contract under paragraph 5 of Schedule 8 to the PA 2023 if one of the below identified risks materialise. Risk 1: The COVID-19 pandemic led to lockdown events, which disrupted the distribution and uptake of some national immunisation campaigns. The forecast delivery and stock requirements were substantially changed as a result. An ongoing risk is the materialisation of a UK health emergency or global pandemic, which may materialise in any given year. How the risk may impact on the performance of the contract: A health emergency or pandemic may materially affect the uptake of the product(s). Continued delivery of the product(s) within the original term of the contract could jeopardise stock management and effective use of product before expiry. Why is it not possible to address the potential impact of such risks? UKHSA and suppliers cannot reasonably predict the occurrence of a pandemic. UKHSA cannot determine an effective delivery schedule and contract term which would be effective during a pandemic to mitigate the risk of reduced uptake."
    },
    "language": "en"
}